A detailed history of Perkins Capital Management Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 16,200 shares of SCPH stock, worth $54,270. This represents 0.07% of its overall portfolio holdings.

Number of Shares
16,200
Previous 18,400 11.96%
Holding current value
$54,270
Previous $80,000 8.75%
% of portfolio
0.07%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$4.12 - $5.51 $9,064 - $12,122
-2,200 Reduced 11.96%
16,200 $73,000
Q2 2024

Aug 09, 2024

BUY
$3.51 - $5.21 $27,378 - $40,638
7,800 Added 73.58%
18,400 $80,000
Q1 2024

May 09, 2024

BUY
$4.86 - $6.39 $51,516 - $67,734
10,600 New
10,600 $53,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $91.8M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.